489 related articles for article (PubMed ID: 27029490)
1. Risks and benefits of psychotropic medication in pregnancy: cohort studies based on UK electronic primary care health records.
Petersen I; McCrea RL; Sammon CJ; Osborn DP; Evans SJ; Cowen PJ; Freemantle N; Nazareth I
Health Technol Assess; 2016 Mar; 20(23):1-176. PubMed ID: 27029490
[TBL] [Abstract][Full Text] [Related]
2. Antidepressants in pregnancy: applying causal epidemiological methods to understand service-use outcomes in women and long-term neurodevelopmental outcomes in exposed children.
Heuvelman H; Davies NM; Ben-Shlomo Y; Emond A; Evans J; Gunnell D; Liebling R; Morris R; Payne R; Storey C; Viner M; Rai D
Health Technol Assess; 2023 Sep; 27(15):1-83. PubMed ID: 37842916
[TBL] [Abstract][Full Text] [Related]
3. Risks associated with antipsychotic treatment in pregnancy: Comparative cohort studies based on electronic health records.
Petersen I; Sammon CJ; McCrea RL; Osborn DPJ; Evans SJ; Cowen PJ; Nazareth I
Schizophr Res; 2016 Oct; 176(2-3):349-356. PubMed ID: 27484686
[TBL] [Abstract][Full Text] [Related]
4. Discontinuation of antipsychotic medication in pregnancy: a cohort study.
Petersen I; McCrea RL; Osborn DJ; Evans S; Pinfold V; Cowen PJ; Gilbert R; Nazareth I
Schizophr Res; 2014 Oct; 159(1):218-25. PubMed ID: 25171856
[TBL] [Abstract][Full Text] [Related]
5. Risks of adverse pregnancy and birth outcomes in women treated or not treated with mood stabilisers for bipolar disorder: population based cohort study.
Bodén R; Lundgren M; Brandt L; Reutfors J; Andersen M; Kieler H
BMJ; 2012 Nov; 345():e7085. PubMed ID: 23137820
[TBL] [Abstract][Full Text] [Related]
6. The effects of gestational use of antidepressants and antipsychotics on neonatal outcomes for women with severe mental illness.
Frayne J; Nguyen T; Bennett K; Allen S; Hauck Y; Liira H
Aust N Z J Obstet Gynaecol; 2017 Oct; 57(5):526-532. PubMed ID: 28386942
[TBL] [Abstract][Full Text] [Related]
7. Atypical antipsychotic use and outcomes in an urban maternal mental health service.
Hatters Friedman S; Moller-Olsen C; Prakash C; North A
Int J Psychiatry Med; 2016 Aug; 51(6):521-533. PubMed ID: 28629296
[TBL] [Abstract][Full Text] [Related]
8. Association Between Prenatal Exposure to Antipsychotics and Attention-Deficit/Hyperactivity Disorder, Autism Spectrum Disorder, Preterm Birth, and Small for Gestational Age.
Wang Z; Chan AYL; Coghill D; Ip P; Lau WCY; Simonoff E; Brauer R; Wei L; Wong ICK; Man KKC
JAMA Intern Med; 2021 Oct; 181(10):1332-1340. PubMed ID: 34398171
[TBL] [Abstract][Full Text] [Related]
9. Psychopharmacological prescribing practices in pregnancy for women with severe mental illness: A multicentre study.
Galbally M; Frayne J; Watson SJ; Snellen M
Eur Neuropsychopharmacol; 2019 Jan; 29(1):57-65. PubMed ID: 30497841
[TBL] [Abstract][Full Text] [Related]
10. Continuation of Atypical Antipsychotic Medication During Early Pregnancy and the Risk of Gestational Diabetes.
Park Y; Hernandez-Diaz S; Bateman BT; Cohen JM; Desai RJ; Patorno E; Glynn RJ; Cohen LS; Mogun H; Huybrechts KF
Am J Psychiatry; 2018 Jun; 175(6):564-574. PubMed ID: 29730938
[TBL] [Abstract][Full Text] [Related]
11. Preliminary findings from the National Register of Antipsychotic Medication in Pregnancy.
Kulkarni J; McCauley-Elsom K; Marston N; Gilbert H; Gurvich C; de Castella A; Fitzgerald P
Aust N Z J Psychiatry; 2008 Jan; 42(1):38-44. PubMed ID: 18058442
[TBL] [Abstract][Full Text] [Related]
12. [Guidelines for the prescription of mood stabilizers for adolescents: A literature review].
Munch G; Godart N
Encephale; 2017 Oct; 43(5):464-470. PubMed ID: 27871720
[TBL] [Abstract][Full Text] [Related]
13. Antipsychotic Use in Pregnancy and the Risk for Congenital Malformations.
Huybrechts KF; Hernández-Díaz S; Patorno E; Desai RJ; Mogun H; Dejene SZ; Cohen JM; Panchaud A; Cohen L; Bateman BT
JAMA Psychiatry; 2016 Sep; 73(9):938-46. PubMed ID: 27540849
[TBL] [Abstract][Full Text] [Related]
14. Maternal use of antipsychotics in early pregnancy and delivery outcome.
Reis M; Källén B
J Clin Psychopharmacol; 2008 Jun; 28(3):279-88. PubMed ID: 18480684
[TBL] [Abstract][Full Text] [Related]
15. Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementia.
Declercq T; Petrovic M; Azermai M; Vander Stichele R; De Sutter AI; van Driel ML; Christiaens T
Cochrane Database Syst Rev; 2013 Mar; (3):CD007726. PubMed ID: 23543555
[TBL] [Abstract][Full Text] [Related]
16. Is higher psychotropic medication burden associated with involuntary treatment under the Mental Health Act? A four-year Australian cohort study.
Wheeler AJ; Hu J; Profitt C; McMillan SS; Theodoros T
BMC Psychiatry; 2020 Jun; 20(1):294. PubMed ID: 32527250
[TBL] [Abstract][Full Text] [Related]
17. Managing Your Own Mood Lability: Use of Mood Stabilizers and Antipsychotics in Pregnancy.
Wichman CL
Curr Psychiatry Rep; 2016 Jan; 18(1):1. PubMed ID: 26685903
[TBL] [Abstract][Full Text] [Related]
18. Pharmacotherapy of mood disorders and psychosis in pre- and post-natal women.
Smith B; Dubovsky SL
Expert Opin Pharmacother; 2017 Nov; 18(16):1703-1719. PubMed ID: 29019422
[TBL] [Abstract][Full Text] [Related]
19. Antipsychotic drugs for non-affective psychosis during pregnancy and postpartum.
Webb RT; Howard L; Abel KM
Cochrane Database Syst Rev; 2004; (2):CD004411. PubMed ID: 15106251
[TBL] [Abstract][Full Text] [Related]
20. Use of psychotropic medication during pregnancy and the postpartum period.
Pearlstein T
Womens Health (Lond); 2013 Nov; 9(6):605-15. PubMed ID: 24161312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
